Goldenwell Biotech dismisses auditor Michael Gillespie & Associates, hires Privatco CPA
Bitget2026/09/29 19:30- Goldenwell Biotech replaced its independent auditor, dismissing Michael Gillespie & Associates on Sept. 27, 2026.
- The former auditor’s reports for fiscal 2025 and 2024 included a going-concern warning over substantial doubt about the company’s ability to continue.
- No disputes were reported with the outgoing auditor on accounting, disclosure, or audit scope during those periods.
- The board engaged Privatco CPA Limited as the new independent registered public accounting firm, effective Sept. 22, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Rising energy prices intensify inflation concerns; US Treasury yields increase again, with the 10-year rising to 5.25%.
Persistently high energy prices have intensified market concerns about the inflation outlook and reinforced investor expectations of further interest rate hikes by the Federal Reserve. After experiencing significant volatility earlier this week, U.S. Treasury yields are edging back toward recent highs.
Bastion Trading reports $78,263 SkyAI common share purchase
Bastion Trading, a 10% owner of SkyAI, bought 44,000 common shares at a weighted average price of $1.7787. Directly held common shares rose to 1,429,417 following the purchase. Indirect beneficial ownership disclosed at 2,940,075 common shares. Derivative exposure included 4,234,615 Pre-Funded Warrants, underlying common stock. Also held 5,384,615 Stapled Warrants, underlying common stock. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. SkyAI Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000921895-26-002775), on October 09, 2026, and is solely responsible for the information contained therein.
Ruanyun Edai gets Nasdaq notice after shares trade below $1 for 30 days
Ruanyun Edai received a Nasdaq notice for failing the $1.00 minimum bid price rule following 30 consecutive business days below $1. The deficiency period ran from Aug. 25 through Oct. 6, 2026, breaching Nasdaq Capital Market Listing Rule 5550(a)(2). A 180-day compliance window runs to April 5, 2027; compliance requires at least $1.00 for 10 consecutive business days. The notice does not immediately affect the stock’s Nasdaq listing or trading. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ruanyun Edai Technology Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610091720PRIMZONEFULLFEED9843090) on October 09, 2026, and is solely responsible for the information contained therein.
Crypto prices
More
